Factores de riesgo de deterioro cognitivo asociado a cáncer en pacientes con carcinoma de mama y colon que reciben tratamiento con quimioterapia

por Iranzo, Patricia, Callejo, Ana, Arbej, Julio, Menao, Sebastian, Isla, Dolores, Andrés, Raquel
Publicado 2023

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

por Isla, Dolores, Sánchez, Alfredo, Casal, Joaquín, Cobo, Manuel, Majem, Margarita, Reguart, Noemi, Zugazagoitia, Jon, Bernabé, Reyes
Publicado 2023

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

por Isla, Dolores, Massuti, Bartomeu, Lázaro, Martín, de Alda, Lucía Ruiz, Gordo, Rocio, Ortega-Joaquín, Nuria, Oyagüez, Itziar
Publicado 2020

Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain

por Isla, Dolores, Lopez-Brea, Marta, Espinosa, María, Arrabal, Natalia, Pérez-Parente, Diego, Carcedo, David, Bernabé-Caro, Reyes
Publicado 2023

A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study

por Isla, Dolores, Felip, Enriqueta, Garrido, Pilar, Insa, Amelia, Majem, Margarita, Remon, Jordi, Trigo, Jose M., de Castro, Javier
Publicado 2022

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

por Isla, Dolores, De Castro, Javier, Juan, Oscar, Grau, Santiago, Orofino, Javier, Gordo, Rocío, Rubio-Terrés, Carlos, Rubio-Rodríguez, Darío
Publicado 2016

Thermal Liquid Biopsy (TLB): A Predictive Score Derived from Serum Thermograms as a Clinical Tool for Screening Lung Cancer Patients

por Rodrigo, Alberto, Ojeda, Jorge L., Vega, Sonia, Sanchez-Gracia, Oscar, Lanas, Angel, Isla, Dolores, Velazquez-Campoy, Adrian, Abian, Olga
Publicado 2019

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Med...

por Isla, Dolores, Lozano, Maria D., Paz-Ares, Luis, Salas, Clara, de Castro, Javier, Conde, Esther, Felip, Enriqueta, Gómez-Román, Javier, Garrido, Pilar, Enguita, Ana Belén
Publicado 2022

Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish...

por Isla, Dolores, Lozano, Maria D., Paz-Ares, Luis, Salas, Clara, de Castro, Javier, Conde, Esther, Felip, Enriqueta, Gómez-Román, Javier, Garrido, Pilar, Enguita, Ana Belén
Publicado 2023

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

por Schwartzberg, Lee S., Horinouchi, Hidehito, Chan, David, Chernilo, Sara, Tsai, Michaela L., Isla, Dolores, Escriu, Carles, Bennett, John P., Clark-Langone, Kim, Svedman, Christer, Tomasini, Pascale
Publicado 2020

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-An...

por Arriola, Edurne, González-Cao, María, Domine, Manuel, De Castro, Javier, Cobo, Manuel, Bernabé, Reyes, Navarro, Alejandro, Sullivan, Ivana, Trigo, José Manuel, Mosquera, Joaquín, Crama, Leonardo, Isla, Dolores
Publicado 2022

Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

por Gascón, Marta, Isla, Dolores, Cruellas, Mara, Gálvez, Eva M., Lastra, Rodrigo, Ocáriz, Maitane, Paño, José Ramón, Ramírez, Ariel, Sesma, Andrea, Torres-Ramón, Irene, Yubero, Alfonso, Pardo, Julián, Martínez-Lostao, Luis
Publicado 2020

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells

por Pesini, Cecilia, Hidalgo, Sandra, Arias, Maykel A., Santiago, Llipsy, Calvo, Carlota, Ocariz-Díez, Maitane, Isla, Dolores, Lanuza, Pilar M., Agustín, M José, Galvez, Eva M, Ramírez-Labrada, Ariel, Pardo, Julián
Publicado 2022

Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients

por Gascón-Ruiz, Marta, Casas-Deza, Diego, Marti-Pi, Maria, Torres-Ramón, Irene, Zapata-García, María, Sesma, Andrea, Lambea, Julio, Álvarez-Alejandro, María, Quilez, Elisa, Isla, Dolores, Arbonés-Mainar, Jose Miguel
Publicado 2022

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

por Ocáriz-Díez, Maitane, Cruellas, Mara, Gascón, Marta, Lastra, Rodrigo, Martínez-Lostao, Luis, Ramírez-Labrada, Ariel, Paño, José Ramón, Sesma, Andrea, Torres, Irene, Yubero, Alfonso, Pardo, Julián, Isla, Dolores, Gálvez, Eva M.
Publicado 2020

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

por Goss, Glenwood D, Cobo, Manuel, Lu, Shun, Syrigos, Konstantinos, Lee, Ki Hyeong, Göker, Erdem, Georgoulias, Vassilis, Isla, Dolores, Morabito, Alessandro, Min, Young J, Ardizzoni, Andrea, Bender, Shaun, Cseh, Agnieszka, Felip, Enriqueta
Publicado 2021

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study

por Viñolas, N. Nuria, Garcia-Campelo, Rosario, Majem, Margarita, Carcereny, Enric, Isla, Dolores, Gonzalez-Larriba, José Luis, Coves, Juan, De-Castro, Javier, Domine, Manuel, Lianes, Piar, Artal, Angel, Remon, Jordi, Felip, Enriqueta, Garrido, Pilar
Publicado 2020

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

por Majem, Margarita, Cobo, Manuel, Isla, Dolores, Marquez-Medina, Diego, Rodriguez-Abreu, Delvys, Casal-Rubio, Joaquín, Moran-Bueno, Teresa, Bernabé-Caro, Reyes, Pérez-Parente, Diego, Ruiz-Gracia, Pedro, Arroyo, Marta Marina, Paz-Ares, Luis
Publicado 2021

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

por Sesma, Andrea, Pardo, Julián, Cruellas, Mara, Gálvez, Eva M., Gascón, Marta, Isla, Dolores, Martínez-Lostao, Luis, Ocáriz, Maitane, Paño, José Ramón, Quílez, Elisa, Ramírez, Ariel, Torres-Ramón, Irene, Yubero, Alfonso, Zapata, María, Lastra, Rodrigo
Publicado 2020

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

por Thomas, Michael, Spigel, David R, Jotte, Robert M, McCleod, Michael, Socinski, Mark A, Page, Ray D, Gressot, Laurent, Knoble, Jeanna, Juan, Oscar, Morgensztern, Daniel, Isla, Dolores, Kim, Edward S, West, Howard, Ko, Amy, Ong, Teng Jin, Trunova, Nataliya, Gridelli, Cesare
Publicado 2017